+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of HIV-1 viral load testing using the Roche Amplicor monitor assay in the diagnosis of recent HIV infection



The role of HIV-1 viral load testing using the Roche Amplicor monitor assay in the diagnosis of recent HIV infection



AIDS 12(Suppl. 4): S74




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033921090

Download citation: RISBibTeXText


Related references

Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Clinical Infectious Diseases 48(2): 260-262, 2009

Evaluation of specimens with undetectable HIV-1 RNA, using the standard Roche amplicor HIV-1 assay, with the Ultrasensitive Roche amplicor HIV-1 assay and HIV-1 Ab testing. Abstracts of the General Meeting of the American Society for Microbiology 101: 689, 2001

Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. Journal of Acquired Immune Deficiency Syndromes 29(4): 330-339, 2002

Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay. Journal of Clinical Virology 49(3): 198-204, 2010

Analytical validation of the Amplicor HIV Monitor assay to measured HIV viral load. Clinical Chemistry 43(6 Part 2): S247, 1997

Comparative analysis of quantification of viral load in patients infected with hepatitis C virus: quantiplex HCV RNA assay and amplicor monitor assay. Revista Espanola de Enfermedades Digestivas 91(8): 569-582, 1999

Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. Journal of Clinical Microbiology 38(3): 1113-1120, 2000

Comparative evaluation of the Roche HIV Monitor Assay and the Organon Teknika Nuclisens NASBA Assay for determining HIV viral load. Abstracts of the General Meeting of the American Society for Microbiology 101: 263, 2001

The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons. Journal of Clinical Virology 35(4): 420-425, 2006

Comparative performance of the Roche COBAS Amplicor assay and an in-house real-time PCR assay for diagnosis of Chlamydia trachomatis infection. Journal of Medical Microbiology 56(Pt 3): 320-322, 2007

Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay. Journal of Acquired Immune Deficiency Syndromes 51(3): 364-365, 2009

Comparative analysis of viral load by bDNA HCV RNA-2.0 and amplicor HCV monitor in patients with hepatitis C infection. Enfermedades Infecciosas Y Microbiologia Clinica 18(1): 6, 2000

Evaluation of Roche Amplicor HCV Monitor Assay. Hepatology 22(4 Part 2): 415A, 1995

Plasma load discrepancies between the Roche Cobas Amplicor human immunodeficiency virus type 1 (HIV-1) Monitor version 1.5 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays. Journal of Clinical Microbiology 46(2): 834; Author Reply 834, 2008

Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. Journal of Clinical Microbiology 45(10): 3436-3438, 2007